Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction
Abstract Background and objectives Few studies have reported which inhaled combination therapy, either bronchodilators and/or inhaled corticosteroids (ICSs), is beneficial in patients with bronchiectasis and airflow obstruction. Our study compared the efficacy and safety among different inhaled comb...
Main Authors: | Hyo Jin Lee, Jung-Kyu Lee, Tae Yeon Park, Eun Young Heo, Deog Kyeom Kim, Hyun Woo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-024-02867-4 |
Similar Items
-
Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2023-06-01) -
Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01) -
Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
by: Sun Hye Shin, et al.
Published: (2022-05-01) -
Favorable Response to Long-Term Azithromycin Therapy in Bronchiectasis Patients with Chronic Airflow Obstruction Compared to Chronic Obstructive Pulmonary Disease Patients without Bronchiectasis
by: Choi Y, et al.
Published: (2021-03-01) -
Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
by: Grace Oscullo, et al.
Published: (2023-10-01)